Stefano Messina
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Correction: Real‑World Response and Super‑Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study.
Journal: Neurology and therapy
Published: July 23, 2026
Migraine with visual aura, unilateral mydriasis and Takotsubo Syndrome. Random coincidence or common pathogenesis? The precarious balance of the autonomic nervous system and the complex relationship between brain and heart: a review of the literature.
Journal: Frontiers in neurology
Published: May 20, 2026
Prevalence and determinants of anxiety in amyotrophic lateral sclerosis.
Journal: BJPsych open
Published: April 24, 2026
ECAS-Based Neuropsychological Phenotyping in Amyotrophic Lateral Sclerosis: A Retrospective Study Comparing Different Algorithms.
Journal: Neurology and therapy
Published: March 19, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study.
Journal: Neurology and therapy
Published: March 18, 2026
Neuropsychological Sub-Phenotypes in Amyotrophic Lateral Sclerosis.
Journal: European journal of neurology
Published: February 06, 2026
Responders and super-responders to atogepant after 24 weeks of treatment in migraine: real-world evidence from the GIANT-2 study.
Journal: The journal of headache and pain
Published: December 20, 2025
Responders and super-responders to atogepant after 24 weeks of treatment in migraine: real-world evidence from the GIANT-2 study.
Journal: The journal of headache and pain
Published: December 20, 2025
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).
Journal: The journal of headache and pain
Published: July 28, 2025
Whole genome sequencing analysis in primary lateral sclerosis (PLS) patients reveals mutations in neurological diseases-causing genes.
Journal: Journal of neurology
Published: July 25, 2025
Unraveling the contribution of executive functions to language impairment in ALS.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: July 21, 2025
GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures.
Journal: The journal of headache and pain
Published: April 20, 2025
Last Updated: 09/26/2026